ES2023532A6 - Procedimiento de preparacion de (s)-*-etil-2-oxo-1-pirrolidinoacetamida> - Google Patents

Procedimiento de preparacion de (s)-*-etil-2-oxo-1-pirrolidinoacetamida>

Info

Publication number
ES2023532A6
ES2023532A6 ES8903978A ES8903978A ES2023532A6 ES 2023532 A6 ES2023532 A6 ES 2023532A6 ES 8903978 A ES8903978 A ES 8903978A ES 8903978 A ES8903978 A ES 8903978A ES 2023532 A6 ES2023532 A6 ES 2023532A6
Authority
ES
Spain
Prior art keywords
oxo
pirrolidinoacetamida
etil
preparation procedure
pyrrolidinoacetamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES8903978A
Other languages
English (en)
Inventor
Eric Cossement
Gnevieve Motte
Jean Pierre Geerts
Jean Gobert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB SA
Original Assignee
UCB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB SA filed Critical UCB SA
Publication of ES2023532A6 publication Critical patent/ES2023532A6/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO DE PREPARACION DE (S) -A-ETIL-2-OXO-1-PIRROLIDINOACETAMIDA, POR HIDROGENOLISIS DE (S) -[2-(METILTIO) ETIL]-2-OXO-1-PIRROLIDINOACETAMIDA EN PRESENCIA DE UN REACTIVO DE DESULFURACION TAL COMO NABH4/NICL2.6H2O, NIQUEL RANEY W-2 O PREFERIBLEMENTE NIQUEL RANEY T-1. LA (S) -A-ETIL-2-OXO-1-PIRROLIDINOACETAMIDA ES UTIL PARA EL TRATAMIENTO Y LA PREVENCIION DE AGRESIONES DE TIPO HIPOXICO E ISQUEMICO DEL SISTEMA NERVIOSO CENTRAL.
ES8903978A 1988-11-23 1989-11-22 Procedimiento de preparacion de (s)-*-etil-2-oxo-1-pirrolidinoacetamida> Expired - Lifetime ES2023532A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888827389A GB8827389D0 (en) 1988-11-23 1988-11-23 Process for preparation of(s)alpha-ethyl-2-oxo-1-pyrrolidineacetamide

Publications (1)

Publication Number Publication Date
ES2023532A6 true ES2023532A6 (es) 1992-01-16

Family

ID=10647345

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8903978A Expired - Lifetime ES2023532A6 (es) 1988-11-23 1989-11-22 Procedimiento de preparacion de (s)-*-etil-2-oxo-1-pirrolidinoacetamida>

Country Status (17)

Country Link
KR (1) KR0157610B1 (es)
CN (1) CN1020604C (es)
AT (1) AT392781B (es)
BG (1) BG51041A3 (es)
CY (1) CY1672A (es)
ES (1) ES2023532A6 (es)
FI (1) FI91961C (es)
GB (2) GB8827389D0 (es)
GR (1) GR1000719B (es)
HK (1) HK102492A (es)
HU (1) HU204508B (es)
NO (1) NO173823C (es)
PH (1) PH26332A (es)
PL (1) PL161781B1 (es)
PT (1) PT92365B (es)
RU (1) RU1797607C (es)
SG (1) SG89392G (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2214147A1 (es) * 2003-02-28 2004-09-01 Farma-Lepori S.A. Procedimiento de obtencion de un agente antiepileptico.

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9319732D0 (en) 1993-09-24 1993-11-10 Ucb Sa Use of (s)-alpha-ethyl-2-oxo-l-pyrrolidineacetamide for the treatment of anxiety
US6107492A (en) * 1998-05-08 2000-08-22 Ucb, S.A. Process for the preparation of levetiracetam
RO121085B1 (ro) 1999-12-01 2006-12-29 Ucb, S.A., Utilizarea levetiracetamului, în tratamentul bolilor sistemului nervos central
GB0004297D0 (en) 2000-02-23 2000-04-12 Ucb Sa 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
RU2216322C1 (ru) * 2002-02-28 2003-11-20 Закрытое акционерное общество "АСГЛ-Фармацевтические Инновации" Средство, обладающее антиишемической, гипотензивной, противоаритмической и ноотропной активностью
CN1802352A (zh) * 2003-02-03 2006-07-12 特瓦制药工业有限公司 制备左乙拉西坦的方法
PL1667967T3 (pl) 2003-09-24 2012-11-30 Ucb Pharma Sa Sposób wytwarzania pochodnych 2-okso-1-pirolidyny
CA2488325C (en) 2004-11-22 2010-08-24 Apotex Pharmachem Inc. Improved process for the preparation of (s)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide and (r)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide
JP2008542323A (ja) 2005-06-01 2008-11-27 ユセベ ファルマ ソシエテ アノニム ２−オキソ−１−ピロリジン誘導体、その製造方法及びその使用
US8338621B2 (en) 2005-12-21 2012-12-25 Ucb S.A. Process for the preparation of 2-oxo-1-pyrrolidine derivatives
WO2009050735A1 (en) * 2007-10-15 2009-04-23 Lupin Limited A novel polymorph of levetiracetam and a process for its preparation
EP2147911A1 (en) 2008-07-24 2010-01-27 ZaCh System S.p.A. Process for the preparation of levetiracetam
US7939676B2 (en) 2009-09-17 2011-05-10 Zach System S.P.A. Process for the preparation of levetiracetam
KR102414246B1 (ko) 2014-01-21 2022-06-27 얀센 파마슈티카 엔.브이. 대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도
LT3431106T (lt) 2014-01-21 2021-02-10 Janssen Pharmaceutica Nv Deriniai, apimantys 2 potipio metabotropinio glutamaterginio receptoriaus teigiamus alosterinius moduliatorius arba ortosterinius agonistus, ir jų panaudojimas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1309692A (en) * 1970-02-13 1973-03-14 Ucb Sa N-substituted lactams
GB8412357D0 (en) * 1984-05-15 1984-06-20 Ucb Sa Pharmaceutical composition
GB8412358D0 (en) * 1984-05-15 1984-06-20 Ucb Sa Pharmaceutical composition

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2214147A1 (es) * 2003-02-28 2004-09-01 Farma-Lepori S.A. Procedimiento de obtencion de un agente antiepileptico.
WO2004076416A1 (es) * 2003-02-28 2004-09-10 Farma-Lepori S.A. Procedimiento de obtención de un agente antiepiléptico

Also Published As

Publication number Publication date
NO173823B (no) 1993-11-01
GB2225322B (en) 1992-03-25
BG51041A3 (bg) 1993-01-15
GB2225322A (en) 1990-05-30
NO894649D0 (no) 1989-11-22
PT92365B (pt) 1995-07-18
FI91961B (fi) 1994-05-31
CN1042904A (zh) 1990-06-13
CN1020604C (zh) 1993-05-12
NO173823C (no) 1994-02-09
KR900007797A (ko) 1990-06-02
RU1797607C (ru) 1993-02-23
HU204508B (en) 1992-01-28
SG89392G (en) 1992-12-04
HUT53072A (en) 1990-09-28
FI91961C (fi) 1994-09-12
FI895562A0 (fi) 1989-11-22
GR890100769A (en) 1990-12-31
HK102492A (en) 1992-12-24
NO894649L (no) 1990-05-25
KR0157610B1 (ko) 1998-11-16
PT92365A (pt) 1990-05-31
GB8926244D0 (en) 1990-01-10
PL161781B1 (en) 1993-07-30
AT392781B (de) 1991-06-10
GB8827389D0 (en) 1988-12-29
CY1672A (en) 1993-05-14
PH26332A (en) 1992-04-29
GR1000719B (el) 1992-11-23
HU896132D0 (en) 1990-02-28
ATA266689A (de) 1990-11-15

Similar Documents

Publication Publication Date Title
DE3370528D1 (en) Lighter, particularly disposable lighter
ES2132105T3 (es) 2-aminometil-cromanos como principios activos en farmacos para el tratamiento de enfermedades del sistema nervioso central.
ZA90394B (en) Alkylated polyethylenimine derivatives,process for their preparation,their use as pharmaceuticals and pharmaceutical preparations
ES2000077A4 (es) Procedimiento mejorado para la regeneracion de residuos que contienencarbono.
ES2132678T3 (es) Sal de nimesulido hidrosoluble y su utilizacion para el tratamiento de las afecciones inflamatorias.
ES2153373T3 (es) Derivados de tienobenzodiazepina para el tratamiento de trastornos del sistema nervioso central.
HK102492A (en) A process for the preparation of (s)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide
ES2104260T5 (es) Procedimiento para la fotocloracion de compuestos alquil-aromaticos.
DE3369158D1 (en) Biologically active ws 6049 substances, a process for the production thereof and their pharmaceutical compositions
ZA853694B (en) Oligosaccharides,their preparation by organic synthesis and their biological applications
IT1152297B (it) Procedimento per l'isomerizzazione di ossido di stirene od omologhi a beta-fenilaldeidi
ES2059457T3 (es) Utilizacion de bezafibrato para el tratamiento de la diabetes.
CA2088064A1 (en) Hydrocarbon treatment
DK450086D0 (da) 12- og 13-bromergolinderivater, fremgangsmaade til fremstilling heraf samt deres anvendelse
ES2163191T3 (es) Procedimiento para la obtencion de 6-aminocapronitrilo.
ES2162211T3 (es) Procedimiento de descarboxilacion de los acidos 2-cetoaldonicos.
BR9813347A (pt) Processos altamente seletivo para preparar uma quinonadiimina e para preparar uma quinonadiimina a partir de uma fenilenodiamina correspondente
MX9505097A (es) 1,4-dihidropiridinas con estructura puente en la posicion 1,2, procedimiento para su obtencion y medicamentos que las contienen.
ES2145807T3 (es) Nuevos aductos de epoxidos y aminas como endurecedores para sistemas epoxidicos acuosos.
GB1430695A (en) Process for the preparation of propargylamine
IL69624A (en) 1,2,3,4-tetrahydro-1-amino-methyl-4-phenyl-isoquinolines and their preparation
NO793794L (no) 7,8,9,10-tetrahydrotieno/3,2-e/pyrido/4,3-b/-indoler, fremgangsmaate til deres fremstilling og deres anvendelse som legemiddel
DE3160074D1 (en) 2,3-dihydrobenzofurans, process for their preparation and pharmaceutical compositions containing them
UA8900A1 (uk) Активний наповнювач-пігмент та спосіб його одержання
ES2033267T3 (es) Procedimiento para preparar un nuevo diaminopirimido-(4,5-d) pirimidin glicosido y glicotido.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20071123